Condition
Hormone Dependent Neoplasms
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04861896Not ApplicableCompleted
A Research Study for Latina Women With Breast Cancer
NCT03849573Not ApplicableCompleted
A Web-Based Tool to Improve Breast Cancer Survivorship
NCT03111615Phase 4UnknownPrimary
HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer
Showing all 3 trials